A memorandum of understanding was signed with China's SpaceSail and the National Data Administration to explore the provision of low-Earth orbit satellite internet in Brazil. This move ...
One of the accords signed Wednesday was on Brazil opening its market to a Chinese satellite company, SpaceSail, that competes with Starlink, founded and run by South African-born US billionaire ...
Elon Musk's Chinese rival in the field of satellite Internet, SpaceSail, intends to start operations in Brazil in 2026. This is what the head of the company from Shanghai told Bloomberg. This may be ...
A new competitor is emerging in the satellite internet race, as Shanghai-based SpaceSail takes aim at disrupting Elon Musk’s Starlink in Latin America. SpaceSail recently signed an MoU with Brazil’s ...
Amid rising tensions over trade policies, Mexico faces a dilemma regarding a potential investment from Chinese electric ...
President-elect Donald Trump's selection of Lori Chavez-DeRemer as Labour Secretary is criticized for her political stance and campaign spending. Federal Election Commission records show that ...
Amid rising tensions over trade policies, Mexico faces a dilemma regarding a potential investment from Chinese electric vehicle manufacturer BYD BYDDY BYDDF. This comes as President-elect Donald ...
Criminals turn college campuses into recruitment hubs, recruiting chemistry students in Mexico with big paydays. By Natalie Kitroeff and Paulina Villegas The mass slaying of West African ...
US-China space rivalry, stalled moon sample swap talks, Shenzhou’s pioneering female space flight engineer and more latest China space news.
The boss of a popular Italian restaurant is retiring after almost 50 years and has put the business up for auction. We take a behind-the-scenes look at how work at a controversial new homes ...
Nov. 12, 2024 — New research has found that people with a genetic defect in their ability to digest sucrose eat less cake, sweets and chocolate, which could hold the key to helping the wider ...
Nov. 27, 2024 — Recent results from a recent clinical trial indicate that a twice-yearly injection of Lenacapavir offers an overall 96% reduced risk of acquiring HIV. This makes Lenacapavir ...